StonvexLoading…
StonvexStonvexStonvexCore line items from PHIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Q3 2020 2020-09-30 | Q2 2020 2020-06-30 | Q1 2020 2020-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-8.79M | $-6.33M | $-4.03M | $-2.36M |
Net Income | $-8.79M | $-6.33M | $-1.67M | $-2.35M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $15.74M | $18.24M | $20.21M | $14.30M |
Total Liabilities | $2.72M | $2.79M | $2.48M | $2.32M |
Cash & Equivalents | $14.29M | $16.92M | $18.91M | $13.33M |
Free Cash Flow OCF − CapEx | $-8.82M | $-6.20M | $-4.22M | $-2.19M |
Shares Outstanding | 5.78M | 5.78M | 5.78M | 2.87M |